Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
17.21
-0.76 (-4.23%)
At close: Mar 20, 2026, 4:00 PM EDT
17.52
+0.31 (1.78%)
After-hours: Mar 20, 2026, 7:54 PM EDT
Apellis Pharmaceuticals Employees
As of December 31, 2025, Apellis Pharmaceuticals had 739 total employees, including 733 full-time and 6 part-time employees. The number of employees increased by 29 or 4.08% compared to the previous year.
Employees
739
Change (1Y)
29
Growth (1Y)
4.08%
Revenue / Employee
$1,358,298
Profits / Employee
$30,295
Market Cap
2.20B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Adaptive Biotechnologies | 624 |
| Galapagos NV | 558 |
| Travere Therapeutics | 497 |
| Wave Life Sciences | 317 |
| Syndax Pharmaceuticals | 298 |
| Day One Biopharmaceuticals | 178 |
| Immunome | 177 |
| Disc Medicine | 155 |
APLS News
- 20 days ago - Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors - GlobeNewsWire
- 26 days ago - Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 27 days ago - Apellis Pharmaceuticals to Present at the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 4 weeks ago - Apellis Announces Eight Oral Presentations at the 49th Macula Society Annual Meeting - GlobeNewsWire
- 5 weeks ago - Apellis Pharmaceuticals to Host Conference Call on February 24, 2026, to Discuss Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600 - PRNewsWire
- 2 months ago - Apellis Valuation Ignores Empaveli Potential, Says Analyst - Benzinga
- 2 months ago - Apellis Highlights Commercial Execution and Strategic Priorities at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire